AU2001294636A1 - Compositions comprising lignin and methods of making and using the same - Google Patents

Compositions comprising lignin and methods of making and using the same

Info

Publication number
AU2001294636A1
AU2001294636A1 AU2001294636A AU9463601A AU2001294636A1 AU 2001294636 A1 AU2001294636 A1 AU 2001294636A1 AU 2001294636 A AU2001294636 A AU 2001294636A AU 9463601 A AU9463601 A AU 9463601A AU 2001294636 A1 AU2001294636 A1 AU 2001294636A1
Authority
AU
Australia
Prior art keywords
making
methods
same
lignin
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294636A
Inventor
Hojabr Alimi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexgel Inc
Original Assignee
Aquamed Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquamed Technologies Inc filed Critical Aquamed Technologies Inc
Publication of AU2001294636A1 publication Critical patent/AU2001294636A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Lignins have a number of bioactivities such as the inhibition of cellular proliferation and inhibition of thrombus formation which are applicable for their use in coating for medical devices and pharmaceuticals. As such, a composition comprising lignins and methods for making and using the same are provided herein.
AU2001294636A 2000-09-20 2001-09-20 Compositions comprising lignin and methods of making and using the same Abandoned AU2001294636A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66583700A 2000-09-20 2000-09-20
US09665837 2000-09-20
PCT/US2001/029661 WO2002024208A1 (en) 2000-09-20 2001-09-20 Compositions comprising lignin and methods of making and using the same

Publications (1)

Publication Number Publication Date
AU2001294636A1 true AU2001294636A1 (en) 2002-04-02

Family

ID=24671759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294636A Abandoned AU2001294636A1 (en) 2000-09-20 2001-09-20 Compositions comprising lignin and methods of making and using the same

Country Status (7)

Country Link
US (1) US20030216326A1 (en)
EP (1) EP1328279B1 (en)
AT (1) ATE440608T1 (en)
AU (1) AU2001294636A1 (en)
DE (1) DE60139702D1 (en)
ES (1) ES2329877T3 (en)
WO (1) WO2002024208A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
CN101934093A (en) * 2009-07-02 2011-01-05 中国科学院金属研究所 Medicament coating material and preparation method
US8569465B2 (en) 2009-07-06 2013-10-29 Wisconsin Alumni Research Foundation Method for modifying lignin structure using monolignol ferulate conjugates
US9487794B2 (en) 2010-07-23 2016-11-08 Board Of Trustees Of Michigan State University Feruloyl-CoA:monolignol transferase
WO2013052660A1 (en) 2011-10-06 2013-04-11 Board Of Trustees Of Michigan State University Hibiscus cannabinus feruloyl-coa:monolignol transferase
WO2013090814A2 (en) 2011-12-16 2013-06-20 Board Of Trustees Of Michigan State University p-Coumaroyl-CoA:Monolignol Transferase
WO2014164418A1 (en) * 2013-03-11 2014-10-09 North Carolina State University Functionalized environmentally benign nanoparticles
US10059650B2 (en) 2013-06-14 2018-08-28 Yale University Systems and methods for the depolymerization of a biopolymer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1512955A1 (en) * 1987-04-06 1989-10-07 Украинский научно-исследовательский институт огнеупоров Method of producing corundum ceramics
JP2923660B2 (en) * 1990-01-06 1999-07-26 宏 坂上 Antiviral agent
WO1993005825A1 (en) * 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
AU3801893A (en) * 1992-05-12 1993-12-13 Church & Dwight Company, Inc. Insecticide compositions
US5849311A (en) * 1996-10-28 1998-12-15 Biopolymerix, Inc. Contact-killing non-leaching antimicrobial materials
US5843741A (en) * 1994-08-01 1998-12-01 Massachusetts Insitute Of Technology Method for altering the differentiation of anchorage dependent cells on an electrically conducting polymer
DE4432126A1 (en) * 1994-09-09 1996-03-14 Lohmann Therapie Syst Lts Implantable moldings for the administration of active substances to plants
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US6037332A (en) * 1996-02-20 2000-03-14 Emory University Method of urinary bladder instillation
US6042600A (en) * 1996-04-26 2000-03-28 Rosenthal; David Radioactive medical devices for inhibiting a hyperplastic response of biological tissue
US5921646A (en) * 1997-07-22 1999-07-13 Kenmark Industrial, Co., Ltd. Combination of easily assemblable and movable cabinet with its engagement components
US5955588A (en) * 1997-12-22 1999-09-21 Innerdyne, Inc. Non-thrombogenic coating composition and methods for using same
US5984927A (en) * 1998-03-03 1999-11-16 Ethicon, Inc. Device for sutureless attachment of soft tissue to bone
US5980973A (en) * 1998-03-13 1999-11-09 Medtronic, Inc. Implantable medical device with biocompatible surface and method for its manufacture
US6050980A (en) * 1998-08-03 2000-04-18 My-Tech, Inc Thromboresistant plastic article and method of manufacture

Also Published As

Publication number Publication date
ES2329877T3 (en) 2009-12-02
ATE440608T1 (en) 2009-09-15
EP1328279B1 (en) 2009-08-26
EP1328279A4 (en) 2005-08-17
EP1328279A1 (en) 2003-07-23
DE60139702D1 (en) 2009-10-08
US20030216326A1 (en) 2003-11-20
WO2002024208A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2007067836A3 (en) Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
HK1135333A1 (en) Method of using diketopiperazines and composition containing them
AU2001268552A1 (en) Flame retardant polycarbonate compositions, method for making and articles made thereby
WO2002030462A3 (en) Hedgehog antagonists, methods and uses related thereto
AU2001251063A1 (en) 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
MXPA03009132A (en) Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors.
AU2001264474A1 (en) Admantane derivatives
AU2001264729A1 (en) Thromboxane inhibitors, compositions and methods of use related applications
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
AU2003297318A1 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2001286701A1 (en) Hyaluronan-based antiadhesion compositions, their preparation and use
AU2001294636A1 (en) Compositions comprising lignin and methods of making and using the same
WO2004032908A3 (en) Method of inhibiting angiogenesis
WO2002030941A3 (en) Topoisomerase inhibitors
UA83203C2 (en) Thiazol-(bi)cycloalkyl-carboxanilides and their use for fighting against undesirable microorganisms
AU6339000A (en) Serotonergic benzothiophenes
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
WO2003077874A3 (en) Substituted tetrahydroisoquinoline compounds, methods of making, and their use
SI1244643T1 (en) Tryptase inhibitors
WO2001046128A3 (en) Tryptase inhibitors